CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05555784
NCT05555784N/ACompleted

Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection

Argo Sante·observational·Posted Sep 27, 2022·Updated Feb 6, 2024

In Brief

An observational study for Leber's Hereditary Optic Neuropathy (LHON). Completed, enrolled 12 participants across 1 site.

Detailed Summary

Leber's hereditary optic neuropathy (LHON) is a rare mitochondrial genetic disorder characterized by optic nerve atrophy due to the degeneration of retinal ganglion cells, which leads to acute visual loss. Males are more likely to develop optic neuropathy than women. They experience blurring or clouding of vision in one eye. The fellow eye develops similar symptoms sequentially with a delay of weeks. This sudden vision loss has devastating consequences on the life course of young men, with the impact of LHON on their quality of life and loss of independence. Yet, data describing the impacts of LHON on the life-course of patients is lacking, with very little data available in the literature. This study aims to understand the life of patients living with LHON disease through the analysis of the impact of LHON on the quality of life and loss of independence of patients living in France and to accurately describe the consequences of the disease on their social, familial and professional life.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
CollaboratorsGenSight Biologics

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 27, 2022
Enrollment StartAug 4, 2022
Primary CompletionFeb 2, 2023
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.8 years ago